Company Name: Rubius Therapeutics, Inc.
Rubius Therapeutics, Inc. is a biopharmaceutical company engaged in the development of Red Cell Therapeutics utilizing its Rubius Erythrocyte Design Platform. The company’s areas of therapeutic focus include autoimmune diseases, cancer and rare diseases.
Ticker Symbol: RUBY (NASDAQ)
Company Website: https://www.rubiustx.com
Headquarters: Cambridge, MA